CSF1R
-related leukoencephalopathy, mainly caused by the mutation of the
colony stimulating factor 1 receptor
(
CSF1R
) gene on chromosome 5, is an underestimated neurological disease typically presenting as early-onset cognitive decline and personality changes. Currently, there is no specific treatment for
CSF1R
-related leukoencephalopathy. Most clinicians failed to recognize this disease during an early disease stage, leading to a high rate of misdiagnosis. Although rare, an increasing amount of
CSF1R
-related leukoencephalopathy cases have been reported recently. In this study, we first report a 35-year-old woman with
CSF1R
-related leukoencephalopathy carrying a novel missense mutation c.2463G >C (p.W821C) of
CSF1R
. An extensive literature research was performed in order to better understand the broader genetic and clinical characteristics of
CSF1R
-related leukoencephalopathy. A total of 147 patients with
CSF1R
-related leukoencephalopathy confirmed either by the genetic test or brain biopsy were identified. Among them, 49 patients were sporadic, and the rest of individuals had a family history originating from 46 different families. Our study indicated that the average age of
CSF1R
-related leukoencephalopathy onset was 41.4 years. Typical clinical symptoms of
CSF1R
-related leukoencephalopathy include cognitive decline, movement disorders, behavior changes and mental disorders. Genetic studies have reported 93 missense mutations, 13 splicing mutations, 6 deletion/insertion mutations, 1 code shift mutation and 1 nonsense mutation of the
CSF1R
gene in patients with
CSF1R
-related leukoencephalopathy. Early genetic detection and brain biopsy would be helpful for a confirmed diagnosis, and more translational studies are needed to combat this devastating disease.